Company / FCF Margin
Celularity Inc FCF Margin History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-12.1%
FY2024
5-year range
-796.2% / -12.1%
FY2021-FY2024
Trend
+93.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -796.2% to -12.1% over the past 2 years.
Based on SEC 10-K filings.
-12.1% in FY2024 with a 3-year CAGR of +533.0%.
Improved from -796.2% to -12.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +533.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin increased 93.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -12.1% | +93.1% |
| FY2023 | -174.5% | +78.1% |
| FY2022 | -796.2% | -46.1% |
| FY2021 | -545.1% | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026